Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Corporation (ADPT $17.41)
- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adaptive Biotechnologies Corporation (ADPT $17.41)
- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Read Answer Asked by Pierre on June 15, 2023

Adaptive Biotechnologies Corporation (ADPT $17.41)
- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Much appreciated,

Read Answer Asked by Jo on March 22, 2021

Amgen Inc. (AMGN $294.26)
- $294.26 P/E (TTM): 23.84X Cap: $157.20B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $188.12)
- $188.12 P/E (TTM): 19.96X Cap: $455.29B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $2.34)
- $2.34 Cap: $125M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $8.39)
- $8.39 P/E (TTM): 3.52X Cap: $1.38B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $149.89)
- $149.89 Cap: $8.13B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $27.33)
- $27.33 Cap: $10.94B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $17.41)
- $17.41 Cap: $2.55B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020